Compound Detail
CHEMBL5181560
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COc1cc(N2CCN(CC(=O)NCCCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(-c4scnc4C)cc3)C(C)(C)C)CC2)c(NC(=O)/C(C#N)=C/C2CC2)cc1Nc1nccc(-c2cn(C)c3ccccc23)n1
Basic Information
| ChEMBL ID | CHEMBL5181560 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | IYEGDDXKUGKHBL-YIBIMTPWSA-N |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
1146.4
MW (Da)
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 35254067 | 10.1021/acs.jmedchem.1c01827 | von Hippel-Lindau disease tumor suppressor/EGFR | 1 |
| 35254067 | 10.1021/acs.jmedchem.1c01827 | NCI-H1975 | 1 |
| 35254067 | 10.1021/acs.jmedchem.1c01827 | HCC827 | 1 |
Data from ChEMBL 36 via Core Engine